Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-12

Clinical Trial Update: Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia [NA]

View source ↗

Summary

Clinical trial evaluating goal-directed therapy to prevent preeclampsia in high-risk pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Pre-Eclampsia, Pregnancy | NA | Status: COMPLETED